Azienda Ospedaliero-Universitaria Pisana - U.O. Oncologia Medica 2 Univ.

Pisa 56126

0 studies enrolling now · 1 studies all time

What they study most

Solid Tumor

Studies at this site

• Phase 1/2 Study of Derazantinib (ARQ 087) in Adult Subjects With Advanced Solid Tumors With FGFR Genetic Alterations — Completed